Search

Search Constraints

You searched for: Author/Creator Edelman, Gerald

Search Results

1. Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors. (30th March 2018)